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Abstract
The post genomic era revealed the need for developing better performing, easier to use and more sophisticated
genetic manipulation tools for the study of Trypanosoma cruzi, the etiological agent of Chagas disease. In this work a
series of plasmids that allow genetic manipulation of this protozoan parasite were developed. First of all we focused
on useful tools to establish selection strategies for different strains and which can be employed as expression
vectors. On the other hand molecular building blocks in the form of diverse selectable markers, modifiable fluorescent
protein and epitope-tag coding sequences were produced. Both types of modules were harboured in backbone
molecules conceived to offer multiple construction and sub-cloning strategies. These can be used to confer new
properties to already available genetic manipulation tools or as starting points for whole novel designs. The
performance of each plasmid and building block was determined independently. For illustration purposes, some
simple direct practical applications were conducted.
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Introduction
Genetic manipulation has played an important role in the
understanding of the biology of Trypanosoma cruzi. In men,
infection with this protozoan parasite produces a condition
known as Chagas disease which affects at least seven million
people [1]. During its life cycle Trypanosoma cruzi, presents
four main developmental stages; replicative epimastigotes and
metacyclic trypomastigotes which are found in the insect vector
while the bloodstream trypomastigote and proliferative
intracellular amastigote reside in the vertebrate host [2]. It has
been shown that this parasite has a complex population
structure with a wide genetic and biochemical diversity among
different strains and natural isolates, accounting for their
particular features regarding eco-epidemiology, pathogenicity
and biology [3]. Consequently there is growing interest in
employing genetic manipulation techniques in order to gain a
better understanding of its biology.
As in other trypanosomatids, the diploid genome is organized
in policistronic gene clusters with tens-to-hundreds of intron
less protein coding sequences arranged sequentially on the
same strand and held apart by intergenic sequences (IS) [4].
These clusters are transcribed by RNA polymerase II into
policistronic transcripts and mRNA maturation for each gene
involves trans-splicing reactions. Centered on a transcribed IS,
the trans-spliceosomal complex is responsible for the
polyadenylation of the upstream gene and the addition of the
spliced leader (SL), a short capped RNA, to the 5´ end of the
downstream gene in a concerted fashion [5]. Furthermore, ISs
are the source of untranslated regions (UTR) which determine
mRNA stability and steady state levels, as well as translation
efficiencies [6]. Consequently, developmental stage specific or
constitutive gene expression profiles are mostly defined by ISs
in a posttranscriptional fashion.
Standard genetic manipulation of Trypanosoma cruzi is
performed with epimastigotes under axenic culture conditions.
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Basic genetic manipulation tools correspond to episomal
expression vectors (EEVs). Mimicking the particular genomic
organization of these organisms, the transgenes are placed in
the same orientation between ISs derived from constitutive
(housekeeping) genes. Analogously, antibiotic resistance
genes flanked by ISs make up trypanosome selectable
markers (SMs). Closed circular plasmids containing such an
alternation of regulatory intergenic and coding sequences can
be stably maintained as autonomous replicating
extrachromosomal molecules [7]. In this type of construct
transcription takes place even in the absence of specific
promoter sequences. The inclusion of RNA polymerase I
ribosomal promoters into EEVs, significantly increases
transgene expression [8] and confers integrative properties,
since such circular constructs have been shown to recombine
into ribosomal loci [9]. The genetic manipulation tools most
frequently used are expression vectors that date to the pre-
genomic era. In order to take advantage of the available
sequence data, genetic systems based on more efficient and
less time consuming construction technologies were developed
for the generation of targeted gene replacement vectors
(TGRVs) [10] and the expression of fusion proteins [11]. In
some cases, attention was paid on producing flexible tools
capable of exchanging different constituting elements [11],
which is a property absent from most of the existing designs.
With TGRVs it has been possible to generate single and
double null mutant T. cruzi strains [10]. Since this trypanosome
lacks RNA interference pathways [12] TGRV based strategies
constitute, to date, the only available alternative to specific
eliminate a gene´s expression product.
This work was focused on the production of two types of
molecular building blocks. The first set of modules correspond
to general purpose SMs. The importance of these molecules
resides in that many methodologies, which imply expression of
multiple transgenes, like inducible expression systems or the
generation of null mutant strains, require successive or
simultaneous transfection and selection steps. The second
group of building blocks correspond to coding sequences for
traceable elements like fluorescent proteins and epitope tags.
These allow the detection of fused proteins of interest and
therefore the production of specifically raised antibodies can be
avoided. In both cases the design maximizes the cloning and
modification possibilities thus allowing a broad range of
applications, from conferring new features to already available
genetic manipulation tools, the development of novel
manipulation constructs to the study of particular genes of
interest.
Materials and Methods
Parasites
Trypanosoma cruzi epimastigotes of the MJ-Levin, Dm28c
and Y strains were grown at 28 °C in 25 cm2 culture flasks
containing 5 mL of LIT medium (devised by Yeager [13])
supplemented with 10% fetal bovine serum, 100 U/mL penicillin
and 100 µg/mL streptomycin. The parental wild type (WT) as
well as all transgenic selected cell lines were routinely
subcultured with weekly passages, for this, fresh medium was
supplemented with the respective antibiotics to the indicated
concentrations and inoculated to 1x106 parasites/mL. Cells
were counted with a hemocytometer.
Plasmid construction
DNA ligase, polynucleotide kinase, Klenow DNA polymerase
and all restriction enzymes, employed were purchased from
New England Biolabs (NEB) except Csp45I and shrimp alkaline
phosphatase which were obtained from Promega. Pfu and Taq
DNA polymerases were respectively purchased from
Fermentas and Sigma. The oligonucleotides used in this work
are listed in Methods S1 and were ordered to Sigma Life
Science. For the construction of pTREXL, pTEXL, pTcR and
pDIY vectors along with their respective accession numbers
see Methods S1. For the construction of TGRV and EEV for
TcADK4 a 2.7 kbp genomic fragment was PCR-amplified with
primers 4F and 4R and cloned into pGEM-T Easy (Promega).
A clone with the fragment inserted in the opposite orientation
relative to the direction of T7 promoter transcription was
isolated and designated pGEM-T Easy L4. A 5.1 kbp fragment
purified from this plasmid after digestion with BamHI and
Csp45I was ligated to Hyg and Neo SMs derived respectively
from pTcR-HG Hyg - and pTcR-GA Neo - by digestion with the
same enzymes. The resulting vectors were designated pL4-HG
Hyg and pL4-GA Neo. Similarly pL4X-HG Neo was produced
inserting the Neo SM of pTcR-HG Neo - into pGEM-T Easy L4
employing the NsiI and SalI restriction enzyme sites present in
both molecules. For the GFP tagged EEV, first a stop codon
was generated immediately downstream from the eGFP gene
of pDIY-eG by digestion with HindIII, treatment with Klenow
DNA polymerase and blunt end religation. Employing BamHI
and Csp45I restriction enzyme sites the fluorescent protein
gene of this plasmid was inserted into pGEM-T Easy L4,
replacing a section of TcADK4, and thus obtaining the
intermediate pL4X-GFP. A 2.4 kbp NsiI-BamHI segment
comprising HG-Neo, intergenic and remaining coding
sequences of pL4X-HG Neo were inserted into pL4X-GFP
generating pL4X-GFP HG Neo.
Plasmid preparation for transfection
For transfections with supercoiled molecules, plasmids were
recovered from 10 mL E. coli cultures grown to saturation in LB
medium [14]. After a standard alkaline lysis [15] supernatants
were incubated for 1 h at 37 °C with 25 µg/mL RNase A
(QIAGEN) and extracted twice with chloroform:isoamyl alcohol
(24:1, v/v). DNA was precipitated by addition of an equal
volume of isopropanol and pellets were combined. For
transfections with linearized plasmids, these were purified from
an equivalent bacterial culture with a single column of the
GenElute™ HP Plasmid Miniprep Kit (Sigma). DNA was eluted
with 100 µL of 1X restriction enzyme buffer and overnight
digested with 20 units of NotI. The linearized plasmid was
precipitated by addition of 10 µL of 3 M Potassium acetate pH
4.8 and 250 µL of 100% ethanol. Pellets obtained by both
methodologies were washed with 70% ethanol, resuspended in
50 µL of TE (10 mM Tris-HCl, pH 8; 1 mM EDTA) and stored at
-20 °C. Each sample which corresponded to approximately 20
µg of DNA was used for a single transfection. In order to
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diminish the chance of culture contamination, prior to
transfection, DNA was heated at 80 °C for 10 minutes. All
plasmids were transfected as circular molecules except those
intended for targeted replacement of the TcADK4 gene which
were linearized with NotI.
Parasite transfections and selection
Epimastigotes grown to a density of 2.5 x 107 cells/mL were
harvested by centrifugation at 3,000 x g for 10 minutes and
washed once with electroporation buffer (PBS: 137 mM NaCl;
2,7 mM KCl; 10 mM Na2HPO4; 2 mM KH2PO4; pH 7.4
supplemented with 0,5 mM MgCl; 0,1 mM CaCl2). Between 2 x
108 and 5 x 108 cells were resuspended in 350 µL of the same
buffer and placed in a 0.2 cm gap electroporation cuvette
containing the previously prepared DNA or TE for mock
transfected parasites. The suspension was subjected to a
single exponential-decay discharge of 400 V and 500 µF (τ≈5
ms) administered with a Gene Pulser Xcell system (Bio-Rad)
and after electroporation the cells were transferred to 5 mL of
medium. Antibiotics were added to the initial indicated
concentrations 24 h post-transfection, and after an additional
24 h period, cell cultures were passaged at a 1:10 dilution
maintaining the antibiotic concentration. Cellular morphologies
and culture densities were monitored periodically by
microscopic inspection for 15 days. Cultures were further
passaged only if, after this period, at least a few motile cells
with normal morphology were detected per field. In order to
avoid low cellular density associated stress, during the first
passages transgenic lines were subcultured at high densities
(diluted 1:5) with unmodified antibiotic concentrations while fast
recovering cultures were diluted up to 1:100 and challenged
with increasing antibiotic concentrations. Further experiments
were carried out with selected parasite populations. Antibiotics:
blasticidin S and phleomycin were obtained from Invivogen,
hygromycin B was purchased from Invitrogen and G418 from
Calbiochem.
Parasite DNA purification and analysis
Approximately 2 x 107 parasites were harvested by
centrifugation at 3,000 x g for 10 minutes, washed once with
PBS and resuspended in 1 mL of lysis buffer (10 mM Tris-HCl,
pH 7.5; 100 mM EDTA; 0.1% SDS). The samples were treated
with 0.5 mL of phenol: chloroform:isoamyl alcohol (25:24:1, v/v)
and the aqueous phase was further extracted once with
chloroform:isoamyl alcohol (24:1, v/v). DNA was precipitated by
addition of an equal volume of isopropanol and spooled up on
a glass rod. DNA was washed with 70% ethanol, resuspended
in 50 µL of 10 mM Tris-HCl, pH 8 containing 25 µg/mL RNase
A (QIAGEN) and stored at 4 °C. For the detection of BSD, ble,
Hyg and Neo resistance genes and the presence of TcADK4
recombinant loci were amplified by PCR with the primers listed
in Methods S1.
Florescence microscopy
Epimastigotes were washed once, resuspended to a density
of 107 cells/mL with PBS, and allowed to settle on poly-L-lysine
coated microscope slides for 10 minutes. Cells were fixed with
a solution of 4% paraformaldehyde supplemented PBS for 10
minutes. Slides were washed with PBS, mounted with anti-fade
mounting medium (PBS, 90% glycerol, 0.2% n-propyl gallate,
1.5 µg/mL DAPI: 4’,6 diamidino-2-phenylindole) and inspected
with an Olympus BX51 fluorescence microscope.
Western-Blot assays
Parasites were washed once with PBS, resuspended in
Laemmli sample buffer [16] (60 mM Tris-Cl pH 6.8, 2% SDS,
10% glycerol, 5% β-mercaptoethanol, 0.01% bromophenol
blue) to a density of 2 x 108 cells/mL and boiled for 10 minutes.
Samples were resolved by SDS-PAGE. Western Blots were
performed using total T. cruzi extracts fractioned by
electrophoresis in polyacrylamide denaturing gels and
transferred to polyvinylidene fluoride (PVDF) membranes. The
PVDF membranes were treated for 1 h with 5% non-fat dry milk
in PBS and then incubated with the primary antibody ON, anti-
GFP rabbit polyclonal (1:5000) (Invitrogen), anti-PAR2 mouse
monoclonal (1:2000), anti-FLAG clone M2 mouse monoclonal
(1:4000) (Sigma), anti-HA clone 3F10 rat monoclonal (1:4000)
(Roche), YL1/2 rat monoclonal (1:4000) (Chemicon) and anti-
ADK4 mouse polyclonal serum (1:2000). Membranes were
washed and incubated with the corresponding horseradish
peroxidase-conjugated secondary antibody, horse anti-mouse
IgG (1:5000) (Vector Labs), goat anti-rabbit IgG (1:5000)
(Vector Labs) and goat anti-rat IgG (1:4000) (Jackson Immuno
Research) for two hours. Detection was done with SuperSignal
West Pico Chemiluminescent Substrate (Pierce) according to
manufacturer´s instructions.
Bioinformatics
Sequence analysis was performed with EMBOSS [17] and
plasmids were designed with Vector-NTI Advance 10
(Invitrogen). Custom made analysis scripts were programed in
Perl (www.perl.org). For the MCSs of pMCS, eight compatible
end restriction enzyme site pairs (EcoRI, MfeI; Acc65I, BsrGI;
NcoI, BspHI; SalI, XhoI; PstI, NsiI; BglII, BamHI; XbaI, NheI
and Csp45I, ClaI) were chosen and the minimum length
overlapping MCSs for all possible 8-member sets considering
all permutations were obtained with an exhaustive search
algorithm (search space = 28 x 8!). Shortest sequences with
sites overlapping dam methylase motifs were selected and
HindIII, NotI, EcoRV and PvuII recognition sites were manually
added. For gene restriction analysis, suitable restriction
enzyme sites were identified in The Restriction Enzyme
Database (rebase.neb.com) and predicted coding sequence
data sets (version 3.2) from T. cruzi CL Brener, T. brucei TREU
927, T. brucei Lister 427 and L. major Friedlin strains were
obtained from TriTrypDB [18] (tritrypdb.org). Perl scripts
specific for pTcR and pDIY vectors are available and can be
adapted for the analysis of other sequences.
Results and Discussion
Selectable marker development
The first objective of this work was the development of novel
SMs for different antibiotic resistance genes. The design was
mainly focused on providing multiple alternatives for
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transferring the SMs to other genetic constructs. Since such a
development would require many genetic engineering
procedures, it was performed in a stepwise fashion. The first
step consisted in the construction of the SMs in the context of
green fluorescent protein (GFP) expression vectors. These
would allow to easily verify if the SMs performed as expected
(i. e. were capable of conferring resistance to their respective
antibiotics). Furthermore these by-product plasmids could
alternatively be employed as general purpose expression
vectors and additionally be helpful in devising and improving
selection schemes according to the local culture and
transfection methodologies employed by each group.
The first four SMs constructed were based on the one
present in the pTEX [7] expression vector with gGAPDH ISs
flanking phleomycin (ble), blasticidin S (BSD), hygromycin B
(Hyg) or G418 (Neo) resistance genes. The addition of a
ribosomal promoter and the IS of TcP2β genes (HX1) upstream
the eGFP coding sequence (Clontech) to each SM yielded a
pTREX [19] like (pTREXL) configuration (Figure 1A). The four
resulting expression vectors were transfected into the recently
typified MJ-Levin strain (Dr. A. Schijman personal
communication) and after electroporation, cells were subjected
to selection with initial antibiotic concentrations conservatively
chosen according to the available literature (Table 1). The
initial selection period lasted approximately a month after which
a large proportion (≈ 80%) of fluorescent cells could be
detected in all cultures except in the ones selected with
phleomycin. Noteworthy the growth rate of these selected lines
were indistinguishable from those of the parental un-
transfected strain. To evaluate the performance of the pTREXL
vectors in different strains, the transfections were repeated
using the Dm28c and Y strain in addition to the MJ-Levin strain.
Initial antibiotic concentrations employed are detailed in Vector
Information S1. Although viable cultures could be obtained for
the transfected MJ-Levin and Dm28c strain, none of the
pTREXL vectors seemed capable of conferring resistance to
the Y strain, since all the cultures relative to it perished. On the
other hand, most of the viable MJ-Levin and Dm28c strain cells
were fluorescent except those transfected with pTREXL-ble.
Noteworthy, after this initial selection scheme, the resulting
cultures were challenged with concentration of antibiotics
lengthy exceeding the IC50s (Table 1) without any effect on
viability.
The failure of the SMs contained in the pTREXL vectors to
confer antibiotic resistance to the Y strain suggested a possible
incompatibility due to the harboured ribosomal promoter
sequence. Additionally the vectors with resistance genes for
antibiotics that target translation (blasticidin S, hygromicin B
and G418) all yielded fluorescent cells when selected in
contrast to phleomycin that targets and damages DNA. For this
reasons the four pTREXL plasmids were modified into more
general EEVs replacing the ribosomal promoter sequence and
the HX1 region with the IS upstream of the gGAPDH I gene
rendering a pTEX [7] like configuration (Figure 1A). These
EEVs were transfectetd, into the three T. cruzi strains used for
pTREXL evaluation. Initial antibiotic concentrations employed
are detailed in Vector Information S1. Selection of these
cultures took considerably shorter, between 15 and 20 days.
The predominant viable cells were fluorescent irrespective of
strain and construct. As expected for EEVs there was a marked
heterogeneity regarding GFP expression levels between
different cells from the same culture (see Results S1).
Once selected, parasites were kept in culture with regular
weekly passages under selective conditions with the highest
antibiotics concentrations in Table 1 for at least two months.
Finally cell extracts were assayed for GFP expression by
Western-Blot (Figure 1B). The absence of expression in cells
transfected with pTREXL-ble could be confirmed. In the
remaining extracts GFP expression levels were comparable.
Western Blot band intensity was quantified and relativized to
PAR2 expression revealing similar expression levels for all the
tested plasmids, indicating similar expression efficiencies.
Transient transfection and selection efficiencies of the
pTREXL-Neo and pTEXL-Neo expression plasmids were
equivalent from those obtained for the related eGFP harbouring
original pTREX and pTEX expression vectors.
Considering host range and initial selection times, pTEXL
vectors performed better than pTREXL equivalents.
Nevertheless cultures transgenic for the latter had more
homogeneous expression patterns.
Development of general purpose selectable markers:
pTcR vector series
Having found that the SMs so far developed could confer
resistance to different antibiotics in different T. cruzi strains, the
next step towards a modular SM design was undertook.
Employing the pTREXL vectors as starting point, the additional
SM series HG and GA (Figure 2) were produced. In the latter
the IS relative to the actin 1 and actin 2 tandem copy genes
[20,21] was inserted downstream from the resistance genes.
As a host vector for the different HG and GA SMs series the
minimal, pUC derived, pMCS plasmid was constructed. The
MCS in this vector was designed so that, upon SM insertion,
the two resulting halves would share some symmetrical
properties. Each side includes sites for rare-cutting and blunt
end restriction enzymes. Additionally there are sites for eight
compatible end restriction enzyme pairs, one on each side of
the cloned SM. For every SM two pTcR vectors were obtained,
corresponding to the two possible orientations of insertion into
pMCS (Figure 2). Given this design the SMs can be easily
subcloned into any of 29 commercially available restriction
enzyme sites irrespective of their order of occurrence and even
if the destination molecule contains only one of these sites at
the desired location. Additionally, for high-throughput
methodologies, the pTcR vectors can be used with the In-
Fusion seamless cloning system [22] (Clontech) or easily
converted to Gateway (Invitrogen) cloning compatible
plasmids. In all, the number of potential destination plasmids
for a pTcR derived SM is very large. See Vector Information S1
for details on how to use In-Fusion or Gateway cloning with
pTcR vectors and for suggested SM transfer strategies to
pTEX [7], pRIBOTEX [8], pTREX [19], pTcINDEX [23] and
pTcGW [11] expression vectors.
The most basic property the pTcR vector series was
expected to fulfill was the capacity to confer resistance to the
respective antibiotics. Consequently epimastigote cells from
New Building Blocks for T. cruzi Gene Manipulation
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the MJ-Levin and Y strains were transfected with each of the
16 members of the pTcR vector series and subjected to
selection with the initial antibiotic concentrations detailed in
Vector Information S1. Depending on the antibiotic the initial
Figure 1.  Expression vectors pTREXL and pTEXL.  (A) Schematic maps. The white box labelled R represents any of the four
antibiotic resistance genes (BSD, blasticidin S deaminase; ble, bleomicin antibiotic family resistance gene; Hyg, hygromycin B
phosphotransferase; Neo, aminoglycoside phosphotransferase). Black boxes are RNA processing sequences, the ones labelled g I,
g I-II and I g II correspond to ISs upstream, relative to and downstream from the gGAPDH tandem copy genes respectively. H
contains the ribosomal protein P2β splice acceptor site and the white triangle inside the grey box represents the ARN pol I
ribosomal promoter (RP). The enhanced green fluorescent protein coding sequence is shown as a grey box labelled eGFP. The
pBluescript II KS + phagemid used as backbone is indicated by the dotted arrows. For an extended restriction map see Vector
Information S1. (B) Western blot analysis of whole cell extracts derived from pTREXL (left) and pTEXL (right) transfected
epimastigote lines. Lanes labelled B, N, H and b correspond to selected cultures maintained at least for two months with 100 µg/mL,
500 µg/mL, 1 mg/mL and 500 µg/mL (pTREXL) or 50 µg/mL, 200 µg/mL, 500 µg/mL and 250 µg/mL (pTEXL) of blasticidin S, G418,
hygromicin B and Phleomycin respectively. After electroblotting membranes where stained with anti-GFP rabbit polyclonal antibody
(top) or anti-PAR2 mouse monoclonal antibody (bottom). Each sample corresponds to 4·106 cells. Below the lanes, eGFP
expression levels relative to those of PAR2 are indicated.
doi: 10.1371/journal.pone.0080217.g001
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selection period lasted between 18 and 28 days. The
concentration of the different selective agents was gradually
increased in successive passages and the parasites were kept
in culture for at least 70 days. The accumulated dilution factor
was approximately 10-12. At this point, it was considered that all
the cell lines had successfully acquired the respective pTcR
encoded resistances. It was expected that the acquired
resistence which exceeded in each case the IC50 for each
antibiotic (Table 1) correlated with the presence of the coding
DNA for each of the respective resistance genes. Therefore,
from each final cellular culture, genomic DNA was obtained
and the presence of pTcR derived material was determined by
PCR amplification of the different resistance genes. Expected
amplification products were obtained for each culture
irrespective of strain and vector (data not shown).
The pTcR vectors are particularly well suited for the
generation of TGRVs. The only additional molecules required
are genomic DNA fragments harbouring the genes of interest
and optional standard cloning vectors (Vector information S1).
To illustrate a simple example of this methodology, TGRVs
were produced for the adenylate kinase 4 gene (TcADK4) [24].
A ≈2.7 Kbp DNA segment containing the gene for TcADK4
along with ISs and fragments of upstream and downstream
coding sequences was cloned into pGEM-T Easy (Promega)
(Figure 3A I). Inserting pTcR derived Neo and Hyg SMs in
replacement of a section of TcADK4, two TGRVs with ≈1 Kbp of
flanking targeting sequences were obtained (Figure 3A II).
These were linearized at restriction enzyme sites of the cloning
vector and transfected into epimastigote cells (Figure 3A III and
IV). Expected PCR-amplification products corresponding to
Table 1. Antibiotic concentrations (µg/mL) employed in this
work.
MarkerDrug IC50 - Strain Construct Reference
  Antibiotic concentrations (µg/mL)  
  MJ Y Mock pTREXL pTEXL pTcR  
ble Phleomycin 52.8 73.3 100 100 →500 250
250
→
500
100 [35] -
500 [36]
BSD Blasticidin S 36.3 22.8 10 -40
10 →
100 50
10 →
50 10 [37]
Hyg HygromycinB 347.2 277.5 250
250 →
1000
250
→
500
200
→
1000
100 [23] -
600 [10]
Neo Geneticin(G418) 121.5 113.0 100 500
100
→
200
100
→
500
100 [7] -
500 [36]
The IC50 values for each drug were obtained for the MJ-Levin and Y strain. The
concentration used during the selection of cells transfected with the vector
developed in this work as well as those for mock transfected parasites are
indicated. Reported lowest and highest concentrations employed by other authors
have been included for comparative reasons. Any concentration inside a given
interval is expressed with a dash while an arrow indicates a gradual increase in
concentration along successive culture passages.
doi: 10.1371/journal.pone.0080217.t001
recombinant regions could be obtained from DNA samples
derived from the respective selected cell lines (Figure 3B).
On the other hand pTcR vectors can be easily used for the
production of EEVs (Vector Information S1). Inserting a HG
Neo SM upstream from the already cloned TzADK4 genomic
fragment the pL4X-HG Neo EEV was obtained (Fig. 3A V). The
TzADK4 expression levels in derived transgenic parasites
(Figure 3C, lane L4) were 54 % higher than those in
equivalents transfected with pTEXL-Neo (Figure 3C, lane G)
produced from the endogenous genes.
A source of traceable elements: pDIY vectors
The second objective of this work was the development of
additional molecular building blocks consisting of traceable
elements. Most of the available vectors used for the expression
of fusion proteins contain the coding sequence for a single
traceable element and, in general, exclusively allow the
addition to either the amino- or carboxyl-terminus of the subject
protein. Consequently for each fusion protein to be assayed an
equal number of vectors has to be acquired or constructed.
Additionally, the subject coding sequence has to be specifically
made compatible for the adequate incorporation into each
different destination vector.
The pDIY vectors (Figure 4A) were constructed in order to
maximise the number of cloning possibilities and therefore the
number of potential resulting fusion proteins with fewer
construction reformulation strategies. These molecules can be
considered as minimum plasmids containing coding sequences
for different traceable elements strategically inserted in frame
between the different restriction enzyme sites of an extended
MCS. Each pDIY vector contains the coding sequence for a
different fluorescent protein and those currently included
correspond to the widely used enhanced green eGFP
(Clontech) and the strictly monomeric mCherry [25] (Clontech)
and mCerulean [26], respective red and cyan newer generation
variants with improved brightness and photo-stability. These
fluorescent proteins can either be fused to the amino- or
carboxy-terminus of proteins of interest. Since the pDIY vectors
are identical beyond these coding regions, any of the
fluorescent protein genes can be employed in the construction
of differently coloured fusion protein expression vectors with
essentially the same cloning strategies and, if later required;
exchanging these elements in general represents a straight
forward task. On each side of the fluorescent protein genes the
pDIY vectors contain coding sequences for epitope tags.
Respectively at the 5´ and 3´ ends the sequences for the 3-
FLAG (Sigma) and influenza virus hemagglutinin HA [27]
epitopes were inserted. The entire coding sequence ends with
the sequence for the strictly C-terminal alpha tubulin (αT)
epitope [28]. For each of the included antigenic determinants
immunoaffinity matrices are commercially available and it has
been shown that bound tagged proteins or complexes to these
can be specifically eluted under gentle nondenaturing
conditions by competition with the respective synthetic epitope
peptides (3-FLAG [29], FLAG [30], HA [31], αT [32]). Since
these elements are all grouped in the same plasmid, the pDIY
vectors constitute good starting points for the development not
only of single step but multiple sequential step immunoaffinity
New Building Blocks for T. cruzi Gene Manipulation
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purification procedures. Therefore considering additional
elution alternatives the sequences for the enterokinase (EK)
[33] and tobacco etch virus (TEV) [34] protease cleavage sites
were placed linking the different traceable elements.
Figure 2.  Schematic maps of pTcR vector series.  The HG and GA selectable marker series contain each of the four antibiotic
resistance genes (BSD,ble,Hyg and Neo; white box R) between the HX1 (H) and gapdh II (g II) or gapdh I-II (g I-II) and actin (a) ISs
(black boxes) respectively. The pMCS host vector is schematized below with the two multiple cloning sites (M and M´) the ampicillin
resistance gene (AmpR) and replication origin (ori). The resulting pTcR vectors obtained cloning each SM into pMCS in either
orientation are shown below. For an extended restriction map of pTcR vector series see Vector Information S1.
doi: 10.1371/journal.pone.0080217.g002
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Figure 3.  Application of developed building blocks in the construction of genetic manipulation vectors.  (A) Diagram
showing the TGRV and EEV constructed for the adenylate kinase 4 (TcADK4) gene. I, pGEM-T Easy with a cloned genomic
fragment comprising TcADK4, ISs (solid bold lines) and flanking coding sequences (light grey boxes). II, TGRVs produced by
replacement of a fragment of TcADK4 with the SMs of pTcR-HG Hyg - and pTcR-GA Neo -. For clarity equivalent sequences in both
constructs are only shown for pL4-GA Neo. III, The TGRVs were linearized and independently transfected into epimastigote cells
(arrow). The homologous recombination events between the constructs and the genomic locus are represented with crossed dotted
lines. IV, resulting recombinant loci and expected amplification products. Primers 4cF and 4cR bind at positions 382 and 440 in the
upstream and downstream genes respectively. Similarly HR, gF, gR and aF are primers specific for the HX1, gapdh II, gapdh I-II
and actin ISs. The systematic ID of the flanking genes is given below. V, EEV generated by insertion of the SM of pTcR-HG Neo -
upstream the cloned fragment containing TcADK4. VI, Tagged EEV obtained after in-frame insertion of eGFP in replacement of a
fragment of TcADK4. The numbers are the lengths, in base pairs, of the respective element above, the amplification products (in I
and IV) or targeting sequences (in III). The letters represent the restriction enzyme sites used in the construction steps. N, NsiI; S,
SalI; B, BamHI; C, Csp45I. (B) PCR analysis of genomic DNA from transgenic (T) and wild type (W) epimastigotes. The constructs
and primer pairs employed in each case are indicated as well as the relevant lengths of the molecular weight marker bands. (C)
Western blot analysis of extracts from wild type (W) and transgenic parasites obtained with pL4x-HG Neo (L4), pL4x-GFP HG Neo
(L4G) and pTEXL-Neo (G). Transgenic parasites were cultured with 100 µg/mL of G418. Top panels derive from membranes
stained with anti-TcADK4 (left) or anti-GFP (right) while bottom panels are equivalents stained with anti-PAR2. Below the lanes,
TcADK4 or GFP expression levels relative to those of PAR2 are indicated. Molecular weights are shown.
doi: 10.1371/journal.pone.0080217.g003
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Figure 4.  pDIY vectors.  (A) Schematic map: The coding sequence contained in the pDIY vectors is represented above. Black
boxes represent FLAG (F), the human influenza hemagglutinin (HA) and alpha tubulin (αT) epitopes. White boxes are enterokinase
(EK) and tobacco etch virus protease (TEV) cleavage sites. The grey box FP represents any of the three fluorescent protein (eGFP,
mCherry and mCerulean) coding sequences available. The minimum backbone vector is schematized with the ampicillin resistance
gene (AmpR) and the bacterial replication origin (ori). Useful restriction enzyme sites are indicated. An extended restriction map can
be found in Vector Information S1. (B) Microphotographs of epimastigotes expressing fusion proteins involving eGFP (top) and
mCerulean (bottom) mixed with equivalents expressing the mCherry variant. The bar at the lower right represents 5 µm. (C)
Western blot analysis of whole cell extracts from epimastigotes transgenic for the different fusion proteins. Lanes labelled G (green),
R (red) and C (cyan) correspond to parasites expressing eGFP, mCherry and mCerulean respectively. Additionally lane WT
indicates samples from the parental epimastigote strain. After electroblotting membranes were stained with anti-FLAG clone M2
mouse monoclonal antibody (FLAG), anti-GFP rabbit polyclonal antibody (GFP) or anti-HA clone 3F10 rat monoclonal antibody
(HA). The predicted molecular weight for the fusion protein is indicated. (D) Extracts from transgenic and WT cell analysed with anti-
alfa tubulin YL1/2 rat monoclonal antibody. Molecular weight markers closest to the bands are indicated. Microphotographs and
extracts were derived from transgenic epimastigotes of the MJ-Levin strain.
doi: 10.1371/journal.pone.0080217.g004
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The pDIY vectors were designed to allow extensive
modifications of the harboured coding sequences. Employing
standard genetic engineering techniques like digestions with
restriction enzymes, optional treatment with DNA polymerases
and ligation, segments can be removed or in frame stop
codons can be generated. Thus from the original coding
sequences at least 23 derived ones can be obtained with
different combinations of elements. On the other hand, being
capable of admitting DNA fragments with cohesive ends
produced by 41 different restriction enzymes, these vectors
constitute good genetic construction platforms. The insertion of
appropriate regulatory elements and SMs can promote these
silent plasmids into expression vectors for different organisms.
Alternatively, the coding sequence can be transferred to
already available expression systems. In the case of T. cruzi,
the inducible pTcINDEX [23] and the Gateway (Invitrogen)
based pTcGW [11], are suitable recipients. Furthermore the
latter can even be extended for C-terminal fusions (see Vector
Information S1 for suggested cloning strategies).
To evaluate the performance of the different traceable
elements simultaneously expressed as a single fusion protein
in Trypanosoma cruzi, the coding sequences contained in the
three pDIY variants were transferred to pTREX [19] expression
vectors. Transgenic epimastigotes of the MJ-Levin were
obtained with the resulting plasmids and these showed
fluorescence distributed throughout the cell body (Figure 4B).
The standard set of filter cubes employed was capable of
distinguishing mCherry from the other two fluorescent proteins
(both Aequorea victoria GFP derivatives). The presence of
each epitope tag was assayed by Western-Blot on whole cell
extracts (Figure 4C). A band of the predicted molecular weight
of the fusion proteins could be detected in membranes
respectively stained with anti-FLAG, anti-GFP and anti-HA
reactive antibodies. The expression levels reached by the
mCherry fusion protein were higher than those observed for the
equivalents with eGFP and mCerulean. In these samples
additional bands corresponding probably to the proteolytic
degradation of mCherry were detected with the anti-HA
antibody. Finally when staining the membranes with YL1/2
(Figure 4D), the band corresponding to the tyrosylated form of
alpha-tubulin could be identified in extracts from transgenic as
well as WT parasites. Under these conditions the expected
additional band corresponding to the fusion protein with the αT
epitope could not be detected.
Having so many cloning capabilities it is likely that a gene of
interest already contains restriction enzyme sites suitable for
the in frame insertion of a pDIY derived traceable element
(Vector Information S1). In this way a BamHI site in TcADK4
allowed the insertion of the eGFP gene of pDIY-eG into pL4X-
HG Neo. The eGFP EEV produced was termed pL4X-GFP HG
Neo (Figure 3A VI). After the selection period, microscopic
examination of epimastigotes transfected with this plasmid
revealed fluorescent protein evenly distributed throughout the
cell body (data not shown). The intensity of the signal was
much lower than that observed in parasites obtained with
pTEXL-Neo. Western-Blot assays confirmed lower expression
levels as well as the expected increase in molecular weight
related to remnants of the N-terminal region of TcADK4 in the
fusion protein (Figure 3C, lanes L4G and G).
Concluding remarks
The plasmids developed in this work represent an integral
contribution to the efforts invested in the genetic manipulation
of Trypanosoma cruzi. By providing means to setup practical
transfection and selection strategies we attempted to help
extend the number of strains on which to conduct these
methodologies. On the other hand, not seeking to replace but
to complement, extend and alternatively work in concert with
already available genetic manipulation tools, we developed
simple molecular building blocks. Additionally, to encourage
creativity, we provided examples illustrating novel ways in
which these functional genetic units can be used with
sophisticated cloning technologies or simply exploiting the
presence of restriction enzyme sites according to cost efficient
methodologies. All vectors are available upon request.
Supporting Information
Methods S1.  Detailed plasmid construction methods. A list
of all oligonucleotides employed in this work along with the
construction steps required for the construction of pTREXL,
pTEXL, pMCS, pTcR and pDIY vector series is provided.
Corresponding GenBank accession numbers are indicated for
each vector.
(PDF)
Results S1.  Transgenic epimastigote microphotographs.
Figures of fluorescent epimastigotes transfected with pTREXL
and pTEXL vectors. An example of parasites simultaneously
expressing GFP and mCherry fusion proteins from different
pTEXL vectors is provided.
(PDF)
Vector Information S1.  Extended restriction maps and
general application guidelines. Detailed maps including
restriction enzyme sites present in the MCSs of pTREXL,
pTEXL, pTcR and pDIY are provided. For each vector, cloning
strategies for the development of novel genetic manipulation
tools or for the extension of already available genetic
constructs are suggested.
(PDF)
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